Belgium· BE-AMP-SAM666026-00
Bimervax LP.8.1
A covid-19, protein-untereinheit product containing sars-cov-2 virus, variant lp.8.1, spike protein, receptor binding domain fusion homodimer, registered in Belgium by Hipra Human Health. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Covid-19, protein-untereinheit is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BN04 (covid-19, protein-untereinheit), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Covid-19, protein-untereinheit · ATC J07BN04
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- SARS-CoV-2 Virus, Variant LP.8.1, Spike Protein, Receptor Binding Domain Fusion Homodimer
- Manufacturer
- Hipra Human Health
- Country
- Belgium (BE)
- ATC code
- J07BN04
- ATC class
- Covid-19, Protein-Untereinheit
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BN04
Covid-19, protein-untereinheit, as other registers publish it.
- PolandBimervaxHipra Human Health, S.L.U.
- BelgiumBimervaxHipra Human Health
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- IcelandBIMERVAXHipra Human Health S.L.
- FinlandBIMERVAXHipra Human Health S.L.
- CzechiaBIMERVAXHipra Human Health, S.L.U., Amer
- DenmarkBIMERVAXHipra Human Health S.L.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef91e43b-1abd-4636-9e1f-c2b8070efd7e GET /v1/drugs/ef91e43b-1abd-4636-9e1f-c2b8070efd7e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dummy Pharmaceutical Form",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Bimervax LP.8.1",
"name_fr": "Bimervax LP.8.1",
"name_nl": "Bimervax LP.8.1",
"amp_code": "SAM666026-00",
"strengths": [
"40.0000",
"40.0000",
"1.1800",
"1.1800"
],
"pack_count": 2,
"substances": [
"SARS-CoV-2 Virus, Variant LP.8.1, Spike Protein, Receptor Binding Domain Fusion Homodimer",
"Disodium Hydrogen Phosphate Dodecahydrate",
"Potassium Chloride",
"Potassium Dihydrogen Phosphate",
"Sodium Chloride",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Covid-19, Protein Subunit",
"authorisation_numbers": [
"EU/1/22/1709/011",
"EU/1/22/1709/012"
]
}See everything about covid-19, protein-untereinheit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.